Drug treatment of epilepsy

British Medical Journal, Jan 9, 1999 by Morgan Feely

[15] Committee on Safety of Medicines, Medicines Control Agency. Vigabatrin (Sabril) and visual field defects. Curr Probl Pharmacovigilence 1998;24:1.

[16] Feely M, Gibson J. Intermittent clobazam for catamenial epilepsy: tolerance avoided. J Neurol Neurosurg Psychiatry 1984;47:1279-82.

[17] British Epilepsy Association. The treatment of epilepsy--a patient's view viewpoint (survey results). Leeds: British Epilepsy Association, 1996.

[18] Mattson RH, Cramer JA, Collins JF. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalised tonic-clonic seizures. N Engl J Med 1992;327:765-71.

[19] De Silva M, McArdle B, McGowan M, Hughes E, Stewart J, Neville BG, et al. Randomised comparative monotherapy trial of phenobarbitone, phenytoin, carbamazepine or sodium valproate for newly diagnosed childhood epilepsy. Lancet 1996;347:709-13.

Clinical Pharmacology Unit, Division of Medicine, University of Leeds, General Infirmary, Leeds LS1 3EX Morgan Feely, senior lecturer

mfeely@ulth. northy.nhs.uk

BMJ 1999;318:106-9